Viagra sales don't meet expectations

May 20, 2007

While sales of erectile dysfunction drugs like Viagra have been steady since their release, their popularity has not met expectations, the Miami Herald said.

The newspaper Saturday reported while initial annual sales estimates for Viagra alone were around $5 billion, the total sales of the top three erectile medications have totaled $3 billion a year.

While sales of the drugs have been somewhat disappointing, they have been credited by some with making erectile dysfunction a less embarrassing medical condition.

"Before Viagra, a lot of men with erection problems were angry and withdrawn in their relationships," sex counselor Dr. Judy Kuriansky said. "They didn't want sex; their partners didn't know what was going on; the women blamed themselves, and it was a mess."

The Herald said that failure of the drug to work for all men may be behind the medication's lack of success as erections only occur in two out of three men when the problem has an organic basis.

Copyright 2007 by United Press International

Explore further: Feds fight morning-after pill age ruling in NY

add to favorites email to friend print save as pdf

Related Stories

EU approves kids' use of Pfizer lung medicine

May 05, 2011

(AP) -- Drugmaker Pfizer Inc. said Thursday that the European commission has approved treating children with its medicine for a rare, deadly lung condition - a drug better known as Viagra.

Illegal-drug sales boom from Internet

Sep 26, 2005

The Internet's speed, efficiency and convenience has drastically changed the way people work and play over the past decade, but it also has changed the way the underground world works -- or so the Japanese authorities are ...

Recommended for you

Feds fight morning-after pill age ruling in NY

11 hours ago

(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...

J&J expects 10-plus new drug applications by 2017

May 23, 2013

(AP)—Johnson & Johnson is developing what could eventually be game-changing treatments for depression and pain, and it's aiming to apply for approval of more than 10 new medicines by 2017, executives said Thursday during ...

Glaxo, US partnering to develop new antibiotics

May 22, 2013

GlaxoSmithKline PLC says it's starting an unusual collaboration with the U.S. government to develop several antibiotics for both bioterrorism threats and bacterial infections resistant to current medicines.

User comments : 0

More news stories

Heart failure accelerates male 'menopause'

Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...

Feds fight morning-after pill age ruling in NY

(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...